Intervention Review

You have free access to this content

Relapse prevention interventions for smoking cessation

  1. Peter Hajek1,
  2. Lindsay F Stead2,*,
  3. Robert West3,
  4. Martin Jarvis4,
  5. Jamie Hartmann-Boyce2,
  6. Tim Lancaster2

Editorial Group: Cochrane Tobacco Addiction Group

Published Online: 20 AUG 2013

Assessed as up-to-date: 5 JUN 2013

DOI: 10.1002/14651858.CD003999.pub4


How to Cite

Hajek P, Stead LF, West R, Jarvis M, Hartmann-Boyce J, Lancaster T. Relapse prevention interventions for smoking cessation. Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD003999. DOI: 10.1002/14651858.CD003999.pub4.

Author Information

  1. 1

    Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Wolfson Institute of Preventive Medicine, London, UK

  2. 2

    University of Oxford, Department of Primary Care Health Sciences, Oxford, UK

  3. 3

    University College London, Department of Epidemiology and Public Health, London, UK

  4. 4

    University College London, Health Behavior Research Centre of Cancer Research UK, Department of Epidemiology and Public Health, London, UK

*Lindsay F Stead, Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, UK. lindsay.stead@phc.ox.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 20 AUG 2013

SEARCH

[Figure 1]
Figure 1.
[Figure 2]
Figure 2. Forest plot of comparison: 6 Pharmacotherapy for assisted abstainers, outcome: 6.2 Bupropion versus placebo. Cessation at least 6 m after end of therapy and at least 12 m after quit date.
[Analysis 1.1]
Analysis 1.1. Comparison 1 Behavioural interventions for abstinent pregnant/postpartum women, Outcome 1 Not smoking at delivery/ last follow-up prior to delivery.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Behavioural interventions for abstinent pregnant/postpartum women, Outcome 2 Not smoking at longest follow-up after delivery.
[Analysis 2.1]
Analysis 2.1. Comparison 2 Behavioural interventions for abstinent hospitalised smokers, Outcome 1 Cessation at longest follow-up.
[Analysis 3.1]
Analysis 3.1. Comparison 3 Behavioural interventions for unaided abstainers, Outcome 1 Cessation at longest follow-up.
[Analysis 4.1]
Analysis 4.1. Comparison 4 Behavioural interventions for assisted abstainers, Outcome 1 Cessation at longest follow-up.
[Analysis 5.1]
Analysis 5.1. Comparison 5 Pharmacotherapy for unaided abstainers, Outcome 1 Cessation 12m after quit date.
[Analysis 6.1]
Analysis 6.1. Comparison 6 Pharmacotherapy for assisted abstainers, Outcome 1 Nicotine replacement therapy versus placebo. Cessation 12 m+ after quit date.
[Analysis 6.2]
Analysis 6.2. Comparison 6 Pharmacotherapy for assisted abstainers, Outcome 2 Bupropion vs. placebo. Cessation 12 m+ after quit date.
[Analysis 6.3]
Analysis 6.3. Comparison 6 Pharmacotherapy for assisted abstainers, Outcome 3 Combination NRT & bupropion vs placebo. Cessation at longest follow-up.
[Analysis 6.4]
Analysis 6.4. Comparison 6 Pharmacotherapy for assisted abstainers, Outcome 4 Varenicline vs placebo. Cessation 12 m+ after quit date.
[Analysis 6.5]
Analysis 6.5. Comparison 6 Pharmacotherapy for assisted abstainers, Outcome 5 Rimonabant vs placebo. Cessation 12 m+ after quit date.
[Analysis 7.1]
Analysis 7.1. Comparison 7 Behavioural interventions for smokers. RP vs. cessation, matched for programme length, Outcome 1 Group or individual format therapy (+/- adjunct pharmacotherapy), cessation at longest follow-up.
[Analysis 7.2]
Analysis 7.2. Comparison 7 Behavioural interventions for smokers. RP vs. cessation, matched for programme length, Outcome 2 Self-help format, cessation at longest follow-up.
[Analysis 8.1]
Analysis 8.1. Comparison 8 Behavioural interventions for smokers. RP vs. cessation, different intensity programmes, Outcome 1 Cessation at longest follow-up.
[Analysis 9.1]
Analysis 9.1. Comparison 9 Interventions for smokers, tests of adjuncts to cessation programmes, Outcome 1 Behavioural interventions, cessation at longest follow-up.
[Analysis 9.2]
Analysis 9.2. Comparison 9 Interventions for smokers, tests of adjuncts to cessation programmes, Outcome 2 Combined behavioural and pharma interventions, cessation at longest follow-up.